Insiders who reported open-market trades in the last 12 months at the companies Amy L. Burroughs files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Amy L. Burroughs is a corporate insider of Tenaya Therapeutics, Inc. (TNYA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Amy L. Burroughs last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 7 filings going back to 2024.
Has Amy L. Burroughs been buying or selling stock?
Recorded transactions: 1 open-market purchase ($110K) and 7 open-market sales ($3.80M) across all tracked filings.
Amy L. Burroughs files SEC Form 4 reports at Tenaya Therapeutics, Inc. (TNYA). 7 SEC Form 4 filings on record going back to 2024, most recently on 29 May 2026. Most recent open-market trade: sold $131K of TERN on 17 March 2026. Lifetime open-market purchases: $110K. Lifetime open-market sales: $3.80M.
Recent transactions
17
The latest 17 SEC Form 4 transactions reported by Amy L. Burroughs.
InsiderAlpha's records for Amy L. Burroughs go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $110K (1 buy totaling $110K). The largest single buy on record is $110K of TERN in 2024. Sales side: 7 recorded sales totaling $3.80M, so the filing history runs sell-heavy by dollar value. 19 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
